Active Ingredient History
Platelet-rich fibrin (PRF) or leukocyte- and platelet-rich fibrin (L-PRF) is a derivative of PRP where autologous platelets and leukocytes are present in a complex fibrin matrix to accelerate the healing of soft and hard tissue and is used as a tissue-engineering scaffold for endodontics. PRF falls under FDA Product Code KST, labeling it as a blood draw/Hematology product classifying it as 510(k) exempt. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Aging (Phase 1/Phase 2)
Alopecia (Phase 3)
Alveolar Bone Loss (Phase 2)
Blood Platelets (Phase 4)
Bone and Bones (Phase 4)
Bone Density (Phase 2)
Bone Diseases (Phase 1)
Bone Regeneration (Phase 4)
Bone Resorption (Phase 3)
Bone Substitutes (Phase 4)
Chronic Periodontitis (Phase 2/Phase 3)
Dental Implantation, Endosseous (Phase 2)
Dental Implants (Phase 1)
Dental Pulp (Phase 2)
Dental Pulp Necrosis (Phase 2)
Dupuytren Contracture (Phase 2/Phase 3)
Erectile Dysfunction (Phase 3)
Eye Diseases, Hereditary (Phase 1)
Furcation Defects (Phase 4)
Gingival Diseases (Phase 4)
Infections (Phase 1)
Inflammation (Phase 3)
Low Back Pain (Phase 4)
Lung (Phase 4)
Maxillary Sinus (Phase 4)
Nasolabial Fold (Phase 1/Phase 2)
Neoplasms (Phase 1)
Periodontal Diseases (Phase 3)
Periodontitis (Phase 4)
Pulpitis (Phase 4)
Ulcer (Phase 1)
Wounds and Injuries (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue